Sorin Group (BIT:SRN) said today it launched its Reply CRT-P cardiac resynchronization therapy pacemaker, claiming it to be the world’s smallest of its kind.
The Reply CRT-P is 11.3 cc in volume, 3.7 cc smaller than Boston Scientific‘s (NYSE:BSX) Intua and 0.2 cc smaller than St. Jude Medical‘s (NYSE:STJ) Anthem CRT-P, according to their respective sites.
The device also features the ability to adapt to heart rate due to exercise and avoid inappropriate reactions, Sorin said. The 1st device was implanted at the Papworth Hospital in Cambridge, UK by Dr. Brian Gordon, Sorin said.
“The small size of the device is very impressive. Size is an extremely important consideration for many patients alongside battery longevity and Reply CRT-P is setting the standard for the former without compromising the latter,” Gordon said.
The pacer also features a sleep apnea monitoring algorithm to detect severe sleep apnea through a ventilation sensor, Sorin said.
“Sorin Group is dedicated to developing solutions for heart failure that enable optimal management of comorbidities such as sleep apnea. Reply CRT-P is another example of this, providing state-of-the-art cardiac resynchronization therapy for HF patients while at the same time enabling the intuitive screening and monitoring of sleep apnea,” cardiac rhythm mangement unit president Stefano Di Lullo said in a press release.
Sorin said yesterday that its 2nd-quarter profits plunged nearly 80% , largely due to costs from its pending, $2.7 billion merger with Cyberonics (NSDQ:CYBX).